Research in Pancreatic Cancer: An Update After ASCO 2012

  • Muhammad Wasif Saif Tufts University School of Medicine. Boston, MA, USA
Keywords: Pancreas, Pancreatic Neoplasms, Carcinoma, Therapeutics, /toxicity


Abstract not available


Download data is not yet available.


Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-2413.

Heinemann V, Boeck S, Hinke A, et al. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer 2008;8:82.

Saif MW, Kim R. Role of platinum agents in the management of advanced pancreatic cancer. Expert Opin Pharmacother. 2007 Nov;8(16):2719-27.

Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-1825.

Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-1966.

Saif MW. Is there a standard of care for the management of advanced pancreatic cancer? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. JOP. J Pancreas (Online) 2008; 9:91-8.

Saif MW, Chabot J. Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard? Nat Rev Clin Oncol. 2011 Jul 5;8(8):452-3.

Gunturu KS, Thumar JR, Hochster HS, Stein S, Yao X, Cong X, LacyJ. Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC). J Clin Oncol 2012; 30(Suppl):Abstract e14534.

Gunturu KS, Jarboe J, Saif MW. Highlights on the first line treatment of metastatic pancreatic cancer. Highlights from the ''2012 ASCO Annual Meeting''. Chicago, IL, USA; May 31 - June 5, 2012. JOP J Pancreas (Online) 2012; July 10th. (In press)

Oettle H, Seufferlein T, Luger T, Schmid RM, von Wichert G, Endlicher E, Garbe C, Kaehler KK, Enk A, Schneider A, Rothhammer-Hampl T, Grosser S, et al. Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen. J Clin Oncol 2012; 30(Suppl):Abstract 4034.

Tufts University. Boston, MA, USA
How to Cite
SaifM. (2012). Research in Pancreatic Cancer: An Update After ASCO 2012. JOP. Journal of the Pancreas, 13(4), 330-331.

Most read articles by the same author(s)

1 2 > >>